Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa
Saved in:
Main Authors: | Ruby S. Gibson, MD (Author), Martina L. Porter, MD (Author), Alexa B. Kimball, MD, MPH (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis
by: Charlotte Greif, MD, et al.
Published: (2024) -
Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study
by: Ruby S. Gibson, MD, et al.
Published: (2024) -
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review
by: Corey L. Snyder, MD, et al.
Published: (2024) -
Response to: Remission of hidradenitis suppurativa after bariatric surgery
by: Nicole Mona Golbari, BA, et al.
Published: (2018) -
The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa
by: D. Jiménez-Gallo, et al.
Published: (2017)